magnolol has been researched along with oleic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, SH; Shen, WJ; Wang, SM; Yeo, HL | 1 |
| Feng, H; Han, L; Li, Z; Liu, G; Lv, H; Shen, B; Tian, Y; Wu, L; Zhang, Q | 1 |
2 other study(ies) available for magnolol and oleic acid
| Article | Year |
|---|---|
Signaling pathway of magnolol-stimulated lipolysis in sterol ester-loaded 3T3-L1 preadipocyes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3T3-L1 Cells; Adipocytes; Animals; Benzylamines; Biphenyl Compounds; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Flavonoids; Glycerol; Hydroxycholesterols; Indoles; Lignans; Lipolysis; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Naphthalenes; Oleic Acid; Phosphorylation; Protein Kinase C; Pyrroles; Signal Transduction; Sulfonamides; Tetradecanoylphorbol Acetate; Vacuoles | 2004 |
Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Fatty Liver; Hep G2 Cells; Humans; Hyperlipidemias; Lignans; Lipid Metabolism; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Oleic Acid; PPAR alpha | 2018 |